Literature DB >> 6430710

Dissociation of responses measured by natural cytotoxicity and chemiluminescence.

M Ernst, A Lange, H D Flad, A Havel, J Ennen, A J Ulmer.   

Abstract

Monocyte/macrophage-mediated cytotoxicity requires the generation of activated oxygen radicals, which can be measured by chemiluminescence (CL). To investigate whether natural killer (NK) cell activity required activated oxygen species, both cytotoxicity against K562 target cells and CL were measured in cell populations of human peripheral blood. The following results were obtained: (a) Peripheral blood mononuclear cells (MNC) showed NK activity and a response in CL, which could be induced by viable or paraformaldehyde-fixed K562 target cells as well as by latex particles. (b) Both T cells and non-T cells exhibited NK activity, but T cells gave no K562- or latex-induced CL responses. (c) Depletion of phagocytic cells from MNC abolished CL, but only marginally affected NK activity. (d) Reconstitution of phagocyte-depleted MNC with adherent cells revealed a superadditive enhanced CL response, but had no augmenting effect on NK activity. (e) Phagocyte-depleted cell populations, enriched for NK activity by density gradient centrifugation, did not respond in K562- and latex-induced CL. (f) MNC, highly enriched for NK activity by cell sorting with a cytofluorograf using the fluorescein isothiocyanate-labeled monoclonal antibody anti-Leu-11a, responded only with reduced CL, whereas the NK activity was enriched up to 45-fold. From these results it is concluded that NK cell-mediated cytolysis of K562 target cells and K562-induced CL are not functionally correlated, but represent properties of two distinct cell populations, namely NK cells and monocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430710     DOI: 10.1002/eji.1830140710

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Monocyte-T-cell interactions in pokeweed mitogen-activated cultures.

Authors:  J Pryjma; M Zembala; A Pituch-Noworolska; M Ernst; J Van der Bosch; H D Flad
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

2.  Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction.

Authors:  C Trezzini; T W Jungi; M O Spycher; F E Maly; P Rao
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

3.  Further evidence against a role for toxic oxygen products as lytic agents in NK cell-mediated cytotoxicity.

Authors:  K P Van Kessel; J A Van Strijp; H J Van Kats-Renaud; L A Miltenburg; M E Van Der Tol; A C Fluit; J Verhoef
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

4.  Change in the chemiluminescence reactivity pattern during in vitro differentiation of human monocytes to macrophages.

Authors:  T W Jungi; E Peterhans
Journal:  Blut       Date:  1988-05

5.  Cytotoxicity by human adherent cells: oxygen-dependent and -independent cytotoxic reactions by different cell populations.

Authors:  K P van Kessel; M R Visser; J A van Strijp; J H van Kats-Renaud; J Verhoef
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

6.  The induction of bacillus-Calmette-Guérin-activated killer cells requires the presence of monocytes and T-helper type-1 cells.

Authors:  A Thanhäuser; A Böhle; B Schneider; N Reiling; T Mattern; M Ernst; H D Flad; A J Ulmer
Journal:  Cancer Immunol Immunother       Date:  1995-02       Impact factor: 6.968

7.  Effects of systemic in vivo interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC).

Authors:  M Ernst; P Kern; H D Flad; A J Ulmer
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

8.  Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity.

Authors:  B Mytar; M Siedlar; M Wołoszyn; I Ruggiero; J Pryjma; M Zembala
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.